Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease

Fibroblast activation protein is dispensable in the anti-influenza immune response in mice

(2017) Sioh-Yang Tan et al.   PLoS One

Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21

(2016) Diana Ronai Dunshee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Neuropeptide Y is a physiological substrate of fibroblast activation protein: Enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinoma

(2016) Pok Fai Wong et al.   PEPTIDES

Fibroblast activation protein (FAP) as a novel metabolic target

(2016) Miguel Angel Sánchez-Garrido et al.   Molecular Metabolism

Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity

(2015) K.H. Williams et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Plasma levels of soluble fibroblast activation protein in arterial thrombosis; determinants and cleavage of its substrate alpha-2-antiplasmin

(2015) Shirley Uitte de Willige et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation

(2014) Brenna Osborne et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy

(2014) Elizabeth J. Hamson et al.   Proteomics Clinical Applications

Circulating concentrations of fibroblast activation protein α in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA

(2013) Jochen Tillmanns et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Increased N-terminal cleavage of alpha-2-antiplasmin in patients with liver cirrhosis

(2013) S. Uitte de Willige et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs

(2013) Fiona M. Keane et al.   FEBS Open Bio

Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α

(2011) Fiona M. Keane et al.   FEBS Journal

Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein- 

(2010) M. Kraman et al.   SCIENCE

The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study

(2009) E. L. E. DE BRUIJNE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS